These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33603575)

  • 1. Daptomycin Pharmacokinetics in Adolescents Undergoing Hemodialysis and Peritoneal Dialysis: A Case Series With Pharmacokinetic Modeling.
    Lim SY; Lewis T; Woo S; Turman M; Bourne DWA; Burton ME; Rianthavorn P
    J Pediatr Pharmacol Ther; 2021; 26(2):123-132. PubMed ID: 33603575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis.
    Patel N; Cardone K; Grabe DW; Meola S; Hoy C; Manley H; Drusano GL; Lodise TP
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1677-83. PubMed ID: 21282429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation.
    Lewis SJ; Jang SM; Mueller BA
    BMC Nephrol; 2023 Sep; 24(1):270. PubMed ID: 37710245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis.
    Butterfield JM; Mueller BA; Patel N; Cardone KE; Grabe DW; Salama NN; Lodise TP
    Antimicrob Agents Chemother; 2013 Feb; 57(2):864-72. PubMed ID: 23208714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysis.
    Yeung SM; Walker SE; Tailor SA; Awdishu L; Tobe S; Yassa T
    Perit Dial Int; 2004; 24(5):447-53. PubMed ID: 15490984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of daptomycin in critically ill patients.
    Soraluce A; Asín-Prieto E; Rodríguez-Gascón A; Barrasa H; Maynar J; Carcelero E; Soy D; Isla A
    Int J Antimicrob Agents; 2018 Aug; 52(2):158-165. PubMed ID: 29572042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in uremia: effect of dialysis modality.
    Mak RH
    Pediatr Res; 1996 Aug; 40(2):304-8. PubMed ID: 8827782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of foscarnet during peritoneal dialysis.
    Alexander AC; Akers A; Matzke GR; Aweeka FT; Fraley DS
    Ann Pharmacother; 1996 Oct; 30(10):1106-9. PubMed ID: 8893116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher KT/V urea associated with greater protein catabolic rate and dietary protein intake in children treated with CCPD compared to CAPD. Mid-European Pediatric CPD Study Group (MPCS).
    Schaefer F; Wolf S; Klaus G; Langenbeck D; Mehls O
    Adv Perit Dial; 1994; 10():310-4. PubMed ID: 7999855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.
    Dahl NV; Foote EF; Searson KM; Fein JL; Kapoian T; Steward CA; Sherman RA
    Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
    Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
    Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pharmacokinetic considerations for the use of daptomycin in patients with Staphylococcus aureus bacteraemia and severe renal impairment.
    Chaves RL; Chakraborty A; Benziger D; Tannenbaum S
    J Antimicrob Chemother; 2014 Jan; 69(1):200-10. PubMed ID: 24030545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of intravenous daptomycin in critically ill patients: implications for selection of dosage regimens.
    Wu J; Zheng X; Zhang L; Wang J; Lv Y; Xi Y; Wu D
    Front Pharmacol; 2024; 15():1378872. PubMed ID: 38756382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study.
    Saint Paul LP; Ficheux M; Debruyne D; Loilier M; Bouvier N; Morello R; Verdon R; Le Blanc E; Cattoir V; Lobbedez T
    Perit Dial Int; 2018; 38(6):463-466. PubMed ID: 30413641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Garenoxacin pharmacokinetics in subjects with renal impairment.
    Krishna G; Gajjar D; Swan S; Marbury T; Grasela DM; Wang Z
    Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic study.
    Kielstein JT; Eugbers C; Bode-Boeger SM; Martens-Lobenhoffer J; Haller H; Joukhadar C; Traunmüller F; Knitsch W; Hafer C; Burkhardt O
    Nephrol Dial Transplant; 2010 May; 25(5):1537-41. PubMed ID: 20031929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous peritoneal dialysis for children: a decade of worldwide growth and development.
    Alexander SR; Honda M
    Kidney Int Suppl; 1993 Feb; 40():S65-74. PubMed ID: 8445841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Benziger DP; Pertel PE; Donovan J; Yankelev S; Schwab RJ; Swan SK; Cannon C
    Clin Nephrol; 2011 Jan; 75(1):63-9. PubMed ID: 21176752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult and pediatric peritonitis rates in a home dialysis program: comparison of continuous ambulatory and continuous cycling peritoneal dialysis.
    Howard RL; Millspaugh J; Teitelbaum I
    Am J Kidney Dis; 1990 Nov; 16(5):469-72. PubMed ID: 2239939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Peritoneal Low-Molecular-Weight-Protein-Removal in CCPD and CAPD Patients Based on C-Terminal Agrin Fragment Clearance.
    Steubl D; Roos M; Hettwer S; Angermann S; Wen M; Schmaderer C; Luppa P; Heemann U; Renders L
    Kidney Blood Press Res; 2016; 41(2):175-85. PubMed ID: 26959245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.